Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Clin Nutr ; 40(6): 4309-4315, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33583660

RESUMO

BACKGROUND & AIMS: The use of long-term taurolidine locks (LTTL) seems to be effective in preventing catheter-related blood stream infections (CRBSI), especially in patients on home parenteral nutrition (HPN). This work targets the cost-effectiveness of LTTL in a cohort of adult HPN patients. METHODS: A monocentric mirror-image design study was conducted in our referral centre among long-term HPN patients experiencing recurrent CRBSI. From 7th January 2011, LTTL were started after the third CRBSI episode within 12 months. CRBSI data was prospectively collected until 7th January 2013, in the same way as it had retrospectively been done before initiating LTTL. A cost-effective analysis was conducted to estimate the incremental costs and effects on CRBSI with LTTL. The efficacy of LTTL on CRBSI rate was assessed over 1000 days of catheter use. RESULTS: A total of 31,100 catheter days were analysed in 37 patients (median [interquartile range (IQR)]) aged 58 [42-68] years. The mean ± SD proven CRBSI rate was 3.18 ± 3.51 per 1000 catheter days before the introduction of LTTL and 0.39 ± 1.50 per 1000 catheter days after its introduction (p < 0.0001). Considering both proven and probable CRBSI requiring hospital management, LTTL reduced by (mean [bootstrap CI 95%]) -2.63 [-3.26 to -2.06] infections per patient (from 2.89 [2.31 to 3.49] before to 0.26 [0.13 to 0.41] after) as well as incremental costs by -7 258 [-10 450 to -4 016] € (from 11 176 [8 004 to 14 968] € before to 3 918 [2 390 to 5 445] € after). CONCLUSION: Implementing LTTL to prevent recurrent CRBSI is cost-effective by dramatically decreasing their incidence.


Assuntos
Infecções Relacionadas a Cateter/prevenção & controle , Cateterismo Venoso Central/efeitos adversos , Cateteres Venosos Centrais/efeitos adversos , Quimioprevenção/economia , Taurina/análogos & derivados , Tiadiazinas/economia , Adulto , Infecções Relacionadas a Cateter/epidemiologia , Quimioprevenção/métodos , Análise Custo-Benefício , Feminino , Hospitalização/economia , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Nutrição Parenteral no Domicílio , Estudos Prospectivos , Recidiva , Projetos de Pesquisa , Estudos Retrospectivos , Taurina/administração & dosagem , Taurina/economia , Tiadiazinas/administração & dosagem , Resultado do Tratamento
2.
PLoS One ; 12(1): e0170258, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28103289

RESUMO

BACKGROUND: Clostridium difficile infection (CDI) is characterized by high rates of recurrence, resulting in substantial health care costs. The aim of this study was to analyze the cost-effectiveness of treatments for the management of second recurrence of community-onset CDI in France. METHODS: We developed a decision-analytic simulation model to compare 5 treatments for the management of second recurrence of community-onset CDI: pulsed-tapered vancomycin, fidaxomicin, fecal microbiota transplantation (FMT) via colonoscopy, FMT via duodenal infusion, and FMT via enema. The model outcome was the incremental cost-effectiveness ratio (ICER), expressed as cost per quality-adjusted life year (QALY) among the 5 treatments. ICERs were interpreted using a willingness-to-pay threshold of €32,000/QALY. Uncertainty was evaluated through deterministic and probabilistic sensitivity analyses. RESULTS: Three strategies were on the efficiency frontier: pulsed-tapered vancomycin, FMT via enema, and FMT via colonoscopy, in order of increasing effectiveness. FMT via duodenal infusion and fidaxomicin were dominated (i.e. less effective and costlier) by FMT via colonoscopy and FMT via enema. FMT via enema compared with pulsed-tapered vancomycin had an ICER of €18,092/QALY. The ICER for FMT via colonoscopy versus FMT via enema was €73,653/QALY. Probabilistic sensitivity analysis with 10,000 Monte Carlo simulations showed that FMT via enema was the most cost-effective strategy in 58% of simulations and FMT via colonoscopy was favored in 19% at a willingness-to-pay threshold of €32,000/QALY. CONCLUSIONS: FMT via enema is the most cost-effective initial strategy for the management of second recurrence of community-onset CDI at a willingness-to-pay threshold of €32,000/QALY.


Assuntos
Clostridioides difficile , Infecções Comunitárias Adquiridas/economia , Infecções Comunitárias Adquiridas/terapia , Enterocolite Pseudomembranosa/economia , Enterocolite Pseudomembranosa/terapia , Aminoglicosídeos/economia , Aminoglicosídeos/uso terapêutico , Antibacterianos/economia , Antibacterianos/uso terapêutico , Simulação por Computador , Análise Custo-Benefício , Árvores de Decisões , Transplante de Microbiota Fecal/economia , Transplante de Microbiota Fecal/métodos , Fidaxomicina , França , Custos de Cuidados de Saúde , Humanos , Modelos Econômicos , Anos de Vida Ajustados por Qualidade de Vida , Recidiva , Vancomicina/economia , Vancomicina/uso terapêutico
3.
JPEN J Parenter Enteral Nutr ; 40(6): 827-34, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-25712958

RESUMO

BACKGROUND: The repeated blackening of in-line filters has been observed during the infusion of parenteral nutrition 2-in-1 mixtures (binary parenteral nutrition [BPN]) delivered in a neonatal intensive care unit. This study aimed to examine the elemental content of precipitates isolated from infused BPN bags and determine the main physicochemical interactions occurring in these bags. MATERIALS AND METHODS: The infusion of BPN mixtures was simulated in vitro following hospital practices. Filter membranes were examined by scanning electron microscopy and energy dispersion spectroscopy (EDS). Amino acid (AA) profiles were obtained from BPN mixtures to determine the concentrations of each AA. RESULTS: Analyzed filter membranes revealed conglomerates of particles on filter surfaces. An EDS analysis generated spectra from isolated particles, identifying copper and sulfur as the major chemical elements. AA mean concentrations were relatively close to the expected value for each AA, except cysteine. Cysteine concentrations were very significantly lower than the expected values. CONCLUSION: A specific interaction was identified between 1 AA (cysteine) and a trace element (copper) in our BPN mixtures.


Assuntos
Aminoácidos/química , Cobre/química , Soluções de Nutrição Parenteral/química , Nutrição Parenteral , Aminoácidos/análise , Fenômenos Químicos , Precipitação Química , Cobre/análise , Cisteína/análise , Cisteína/química , Filtração/instrumentação , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Microscopia Eletrônica de Varredura , Análise Espectral , Enxofre/análise , Enxofre/química
4.
J Oncol Pharm Pract ; 21(2): 102-10, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24519187

RESUMO

PURPOSE: The aims of the study are to make an inventory of fixtures of aseptic compounding structures, to compare, using real examples, the design and operating costs of controlled atmosphere area (CAA) with isolators and CAA with laminar flow biological safety cabinets (BSCs) in order to determine the most economical scheme in hospitals and to give a final facilities cost calculated for one workstation. METHODS: Forty-three hospitals were interviewed (21 French and 22 from four European countries) over seven months. Hospital pharmacists completed a form with 390 items. Hospitals are compared according to their workstation type: BSCII or BSCIII (group B) and isolator (group I), using Mann and Whitney's statistical test and Monte-Carlo modeling. RESULTS: Twenty-one hospitals responded (11 French and 10 from other European countries). All European compounding unit organizations are not significantly different. The study compared items such as infrastructure cost, equipment cost, staff cost, consumable cost, cleaning cost and control cost. A synthesis of all costs has been drafted to calculate an estimated preparation cost which seemed to be higher for group B than for group I when staff costs were included ($46 and $31, respectively, in study conditions). CONCLUSIONS: The different costs studied have revealed little significant difference between group B and I. The preparation cost in group B appears higher than in group I. This pilot study has resulted in the calculation of an estimated manufactured preparation cost but this work should be completed to help optimize resources and save money.


Assuntos
Assepsia , Composição de Medicamentos/economia , Contaminação de Medicamentos/economia , Contaminação de Medicamentos/prevenção & controle , Custos de Medicamentos , Ambiente Controlado , Custos Hospitalares , Serviço de Farmácia Hospitalar/economia , Assepsia/métodos , Controle de Custos , Análise Custo-Benefício , Equipamentos Descartáveis/economia , Composição de Medicamentos/métodos , Europa (Continente) , Humanos , Modelos Econômicos , Método de Monte Carlo , Serviço de Farmácia Hospitalar/organização & administração , Projetos Piloto , Salários e Benefícios
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA